image credit: Freepik

Regeneron’s Inmazeb Becomes First Ebola Treatment Approved by FDA

October 15, 2020

Via: BioSpace

Although Regeneron Pharmaceuticals has been in the news lately for its antibody cocktail against COVID-19 that was used to treat President Trump, it’s not the only arrow in the company’s quiver. Today it announced that the U.S. Food and Drug Administration (FDA) approved Inmazeb, a three-antibody cocktail to treat Ebola infections in adults and children. It has also been approved for newborns of mothers who have tested positive for Ebola.

Read More on BioSpace